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Ma~oc~onal antibody djsc~rninat~~g betwen endothelial and smooth muscle ceils is suggested to be used 
as a vector for directed transport of drugs to injured (denuded) areas of blood vessel wall. An in vitro model 
system was used in the studies: vascular smooth muscle or endoth~~~a~ cellsgrown on plastic surface were 
treated with specific mouse mon~lonal antibody recognizing an antigen localized on the surface of smooth 
muscle rather than endothelial cells; then erythrocytes coated with secondary (rabbit antimouse) antibodies 
were added. The results were analyzed spectrophotometrically or with scanning electron microscopy. Under 
the experimental conditions, erythrocytes, possible ‘containers’ for carrying the drugs, were found to bind 
only to smooth muscle cells. The data show that antibody provides absolute discrimination between endo- 
theliai and smooth muscle cells and, thus, may be used as a vector for drug targeting. 
Drug targeting 
Specific cell markers have a wide range of ap- 
plications in developmental biology, cell biology 
and physiology. They may be used for tissue typ- 
ing, propagation of organ cultures, monitoring of 
cell differentiation in vitro and drug targeting. The 
targeting of drugs seems to be a promising ap- 
proach in treatment of many diseases [l--7]. The 
main principle in this method is as follows: 
delivery of drug is directed by a vector molecule, 
antibody or any other specific ligand which is able 
to interact with a target, that may be, for instance, 
a certain group of the cells within an organ or 
tissue. Very often it is important to create and to 
maintain a high concentration of the drug locally 
in the area where a pathological process takes 
place. In such a situation drugs may be delivered in 
‘containers’ - special reservoirs, natural or 
prepared in vitro, that would serve to carry a por- 
tion of drug to a desired organ or tissue and also 
to protect it. Liposomes and red blood cells or 
their ghosts are possible candidates for use as con- 
tainers [S-IO]. Both liposomes and erythrocytes 
may be injected into the bl~dstream and then 
deliver drugs to a target exposed to the circulation 
system. One of the serious problems involved is to 
provide specificity of delivering, i.e. a vector for 
targeting. MonaclonaI antibodies are supposeif to 
be good vectors because of the high specificity af 
their interaction with antigens. 
Morphological studies show that endothelial in- 
jury is one of the pathogenetic components of 
many ~ardiovascul~ diseases [ 1 l-14]. The 
underlying layers of the vessel wall become ex- 
posed to the bloodstr~m as a result of mechanical 
disintegration and increased permeability of the 
endoth~lium, so that circulating substances that 
may affect me~bolism, proliferation, and contrac- 
tile and secretory activity of the cells inhabiting 
subendothelial layers can reach them. The delivery 
of drugs - low& substances or enzymes - to such 
a focus of a pathological process seems to be a pro- 
mising approach in the treatment of 
atherosclerosis or other diseases that involve the 
vascular wall. A ligand that would specifically bind 
to compounds of s~bendotheiial layers could be a 
vector in this case, Recently, a cunjugate of ricin (a 
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plant toxin) with a mono~l5nal antibody to a sur- 
face antigen of rat aorta smooth muscle cells was 
reported t5 inhibit spec~~~~ly protein biosynthesis 
in target smooth muscle cells [15]. 
We have developed a monocional antibody 
recognizing an antigen of M, 330000 localized on 
the surface of smooth muscle cells of human aorta 
[16]. Endothelial cells from human aorta and um- 
bilical vein do not contain the antigen. This an- 
tibody which discriminates between endothelial 
and smoath muscle cells is a possible vector for the 
delivery of drugs to the injured (denuded~ area of 
the vessel wall where subendothelial ayers are 
exposed. 
2. MATERIALS AND METHODS 
A culture of smooth muscle cells from human 
aorta was prepared according to Ross and Glomset 
[ 171. Cells were used between the 6th and 8th 
passages. Endothelial cells from human aorta were 
a generous gift from Dr S. Danilov (USSR Car- 
diology Research Center, Moscow, USSR). To 
prepare mixed cultures endotheliai cells were seed- 
ed (iOOO0 ceils per well) in 24-well tissue cuhure 
plates (Flow), on the third day of ~uitivat~5n 
smooth muscle cells were added at a density of 
10000 ceils per well and after 2 more days the 
cultures were used for experiments, Monocional 
antibody IIGlO was prepared as described in [16]. 
A preparation used here was obtained by precipita- 
tion with (NH&S04 (50% of saturation) from 
ascitic fluid. The antibody (O&02-30pg/ml) was 
added to living ceils in culture medium sup- 
plemented with l@% human serum, and after 
30 min incubation at 37°C in an atmosphere of 6% 
CQ&#% air unbound antibody was removed by 
washing with culture medium, Red blood ceils 
were separated by ~en~fugat~Qn of heparin- 
anticoagulated human blood and washed in saline. 
Affinity-purified rabbit anti-mouse l&G was con- 
jugated to washed erythrocytes by CrCll as in [ 181. 
Briefly, equal volumes of 50% (v/v) erythrocyte 
suspension and antibodies (3 mg/ml) were mixed 
together and vortex-mixed in CrCl3 prepared on 
saline for 30 min at 20°C. To prevent aggregation 
red blood ceils were suspended in saline containing 
IO mg/mi BSA and then washed by ce~tr~fugat~on~ 
To evaluate the amount of bound antibodies lZ51- 
IgG was added as a tracer before c5njugat~on. A
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standard prep~ation contained 2 x 10’ molecules 
of IgG bound per erythrocyte. An erythrocyte 
suspension (0.5-2%, v/v) was added to the ceils 
grown in tissue culture plates and pretreated with 
specific antibodies, Centrifugation far 3 min at 
1000 rpm in a Beckman TJ 6 centrifuge resulted in 
even distribution of erythrocytes on the bottom of 
the well. After 15 min incubation at r5om 
temperature the plate was centrifuged again, this 
time being tilted at 45” to the axis. As a result of 
this procedure unbound red blood ceils moved 
down to the edges of the wells while specifically at- 
tached erythrocytes were retained on the surface of 
the cultured ceils. The bottom of the ‘positive’ well 
was coated with erythrocytes, so they appeared 
red, whereas in the clean ‘negative’ wells ail the 
erythrocytes were found in a narrow haif-moon 
band at he very edge of the well. The absorbance 
in the wells of the 96-well plates was determined 
with a Microelisa MR 580 autoreader (Dynatech) 
at 405 nm. For scanning electron microscapy the 
samples prepared in the wells of the 24-well plates 
were fixed with 2.5% glutaraidehyde overnight at 
4”C, then the bottom of each well was cut out, the 
samples dehydrated in ethanol, dried in a critical 
p5int drier (Witachi, HCP-2) and analyzed with 
30 I.? 0.24 OJX 
ANTIBODY CONCENTRATION,&ML 
Fig. 1. Monoclonal antibody-directed binding of 
erythrocytes to smooth muscle cells. (Circles) Smooth 
muscle cells were treated with monoclonal antibody 
IIGIO (open symbols) ix non-immune mouse 
~mmunog~obulins (closed symbols) and then eryth- 
rocytes coated with secondary antibodies were added. 
(Squares) ~ndothe~~~ cells were pretreated with 
monoclonal antibody followed by erythrocytes. 
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scanning 
&vMO), 
electron microscope (Philips, 
3. RESULTS AND DISCUSSION 
To demonstrate that monoclanal antibody 
IIClO which distinguishes between endothelial and 
smooth muscle ceils may be used as a vector for 
drug targeting, we have carried out an experiment 
according to the following scheme: (i) cells (en- 
dothelial or vascular smooth muscle) were grown 
in 96- or 24-we11 tissue culture plates; (ii) specific 
antibody (IIGIO) was added to the cells; (iii) un- 
bound antibody was removed by washing with 
culture medium; (iv) erythrocytes precoated with 
secondary antibody (rabbit antimouse im- 
munoglobulins) were added to the cells; (v) un- 
Fig.2. Scanning electron micrographs of smooth muscle 
cells coated with erythrocytes. MonocfonaI antibody- 
directed binding of red blood cells to smooth muscle 
cells was performed as described in the text. (A) Smooth 
muscle cells coated with erythrocytes. General view of 
the culture, x 260. (B) Higher magnification. x 1350. 
bound erythrocytes were removed by centrifuga- 
tion to the edges of the wells; (vi} plates were 
analyzed spectrophotometricdly or by means of 
scanning electron microscopy. 
Fig. 1 shows monoclonal antibody IIGlO- 
directed binding of the red blood cells to smooth 
muscle cells, The antibody was still active at 
0.24 @g/ml, while endothelial cells treated with this 
antibody did not bind any erythrocytes. Smooth 
muscle cells coated with red blood ceils are shown 
in fig.2. In rather sparse cultures erythroeytes are 
distributed on the bottom of the weH foliowing the 
Fig.3. Scanning efectron micrograph of co-cultivated 
smooth muscle and endotheiiai celIs. A cell culture was 
pretreated with antibody ffGf0 and then red blood cells 
carrying secondary antibody were added. ~ndotheii~ 
cells are denoted by the arrowheads. (A) x 1560. (B) 
x 1400. 
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contours of the cells and it can be clearly seen that 
they do not stick to the plastic surface at all 
(fig.2A). 
To show that the method used here provides 
really high specificity based on the properties of 
monoclonal antibody IIGlO, we co-cultured 
smooth muscle and endothelial cells, and then used 
these mixed cultures for the experiments carried 
out according to the scheme described above. Mor- 
phologically endothelial and smooth muscle cells 
differ significantly - in general smooth muscle 
cells are spread more widely and of irregular 
shape, while endothelial cells form characteristic 
islets (see fig.3), thus enabling one to distinguish 
between them on a micrograph. In the mixed 
cultures red blood cells bound only to smooth mus- 
cle cells, the surface of endothelial cells being ab- 
solutely clean. Thus, monoclonal antibody IIGlO 
used as a vector in our studies enables to 
discriminate between endothelial and smooth mus- 
cle cells growing in mixed culture as well. 
We conclude that antibody IIGlO providing 
really high specificity may be used for drug 
targeting to an injured surface of a blood vessel 
wall. 
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